What is Edison?
Edison operates at the intersection of artificial intelligence and laboratory science. Spun out of FutureHouse, the company provides a sophisticated platform designed to augment the capabilities of research institutions and enterprise organizations. Its core product, Kosmos, serves as an integrated AI workflow engine that handles the heavy lifting of data synthesis and experimental design. By leveraging advanced machine learning models, Edison enables researchers to focus on high-level innovation while the platform manages the iterative processes of scientific inquiry. This market position places Edison at the forefront of the 'AI for Science' movement, a sector currently experiencing rapid adoption as organizations seek to optimize R&D efficiency and reduce the cost of discovery.
How much funding has Edison raised?
Edison has raised a total of $70M across 1 funding round:
Seed
$70M
Seed (2025): $70M with participation from Susa Ventures, Pillar VC, Triatomic Capital, Hawktail, Spark Capital, Olive Capital, and Striker Venture Partners
Key Investors in Edison
Susa Ventures
Susa Ventures is an early-stage venture capital firm that invests in seed-stage startups, aiming to help build the next billion-dollar companies.
Pillar VC
Pillar VC is a Boston-based venture capital firm specializing in early-stage and seed funding, aimed at supporting founders in their professional and personal growth.
Triatomic Capital
Triatomic Capital is an investment firm focused on deep tech, health tech, and new economy sectors, particularly in AI and automation.
What's next for Edison?
With the support of this major enterprise-level funding, Edison is poised to transition from its initial development phase into a period of aggressive commercial scaling. The strategic roadmap likely involves expanding the capabilities of the Kosmos platform to support a wider array of scientific domains, including advanced materials science and complex drug discovery. As the company matures, the focus will shift toward establishing deep integrations within existing research infrastructures, ensuring that its automated workflows become the standard for high-throughput scientific environments. Investors are closely watching how Edison will navigate the competitive landscape of AI-driven automation, particularly as it seeks to prove the long-term efficacy and scalability of its molecular design tools in real-world, high-stakes research settings.
See full Edison company page
